Using Fludarabine and Melphalan Conditioning Regimen for CLL,Lymphoma,Multiple Myeloma
NCT00772811
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
38
Enrollment
NETWORK
Sponsor class
Conditions
Chronic Lymphocytic Leukemia
Lymphoma
Multiple Myeloma
Interventions
DRUG:
Flu-Mel
Sponsor
Cooperative Study Group A for Hematology